Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C000590786
http://purl.bioontology.org/ontology/MESH/C000590786
|
|---|---|
| Preferred Name | lorlatinib |
| Synonyms |
PF06463922
Lorbrena
7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
loratinib
PF-06463922
(10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel | PF06463922
Lorbrena
7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
loratinib
PF-06463922
(10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile
See more
See less
|
|---|---|
| prefLabel | lorlatinib
|
| Scope Statement | inhibits both anaplastic lymphoma kinase and c-ros oncogene 1 (ROS1) protein
|
| type | |
| tui |
T109
T121
|
| HM |
D007769
D011720
D000631
|
| SC | 1
|
| TERMUI |
T000864746
T000982502
T000893819
T000864745
T001111470
T000871177
T001111469
See more
See less
|
| TH |
NLM (2016)
NLM (2020)
FDA SRS (2017)
NLM (2015)
NLM (2021)
USAN (19XX)
INN (19XX)
NLM (2014)
See more
See less
|
| SRC | J Med Chem. 2014 Jun 12;57(11):4720-44.
|
| MMR | 20210909
|
| notation | C000590786
|
| Semantic type UMLS property | |
| cui |
C4080091
C4735286
C3827088
C3884739
|
| MeSH Frequency | 187
|
| LT | TRD
|
| DSC | 20140817
|
| Inverse of RB |
OSP71S83EU
0
|
| Mapped to | |
| MDA | 20140817
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |